TY  - GEN
TI  - Darunavir (Prezista) for HIV infection
SN  - 0025-732X
PY  - 2006///1016
KW  - Antiretroviral Therapy, Highly Active
KW  - methods
KW  - Biological Availability
KW  - Blood Proteins
KW  - metabolism
KW  - Cytochrome P-450 CYP3A
KW  - Cytochrome P-450 CYP3A Inhibitors
KW  - Darunavir
KW  - Drug Approval
KW  - Drug Interactions
KW  - Drug Resistance, Viral
KW  - Enfuvirtide
KW  - HIV Envelope Protein gp41
KW  - pharmacology
KW  - HIV Infections
KW  - drug therapy
KW  - HIV Protease Inhibitors
KW  - pharmacokinetics
KW  - HIV-1
KW  - drug effects
KW  - Humans
KW  - Peptide Fragments
KW  - Protein Binding
KW  - RNA, Viral
KW  - blood
KW  - Randomized Controlled Trials as Topic
KW  - Ritonavir
KW  - Sulfonamides
KW  - Tablets
KW  - Time Factors
KW  - United States
KW  - Viral Load
N1  - Publication Type: Journal Article
ER  -